1st Edition

Coronary Atherosclerosis Current Management and Treatment

    470 Pages
    by CRC Press

    470 Pages
    by CRC Press

    Continue Shopping

    The prevalence of coronary artery disease is increasing due to rising rates of obesity and the fact that a greater number of people are living longer. Coronary Atherosclerosis: Current Management and Treatment addresses this leading cause of death worldwide.

    Atherosclerosis has a broad range of disease manifestations depending on the degree of the stenosis and the functional status of the coronary plaque. This volume, written by a leading international team of editors, addresses the pathophysiology of the disease, established and novel diagnostic approaches (both invasive and non-invasive), treatment methodologies (including treatment algorithms), and differing perspectives on treatment, including future therapies and long-term outcomes. The inclusion of personal perspectives from experts, full-color images and ancillary video files make this a key resource.

    Key topics include:

    • Pharmacology of coronary artery disease (CAD)

    • Up-to-date evidence on pathophysiology

    • Invasive and non-invasive imaging

    • Current evidence for risk stratification

    • Clinical decisionmaking

    Coronary Atherosclerosis: Current Management and Treatment provides a state-of-the-art review of current knowledge to aid specialists, general physicians, and cardiologists in training, in the diagnosis, risk stratification, and management of patients with diverse presentations of coronary atherosclerosis.

    The Pathophysiology of Coronary Atherosclerosis. Diagnostic Approach to Coronary Atherosclerosis: Non Invasive Approach. Diagnostic Approach to Coronary Atherosclerosis: Invasive Approach. Treatment methodology of coronary artery disease. Treatment approach to coronary artery disease: Diverse perspectives.


    Chourmouzios Arampatzis, MD, PhD,FESC, Senior Interventional Cardiologist, Interbalkan Medical Center, Thessaloniki, Greece

    Eugene P. McFadden MB, BCh, BAO, DCH, MRCP(UK), FRCPI, FESC, FACC, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands and Interventional Cardiologist, Cork University Hospital, Wilton, Cork, Ireland

    Lampros K. Michalis MD, Professor in Cardiology, Department of Cardiology, Medical School, University of Ioannina, Greece

    Renu Virmani, M.D, President and Medical Director, CVPath Institute, Inc., Gaithersburg, Maryland, USA

    Patrick W. Serruys MD, Head of the Interventional Dept., Heartcenter Rotterdam, Rotterdam, The Netherlands